At a glance
ClinicalIndex Comparison RecordN/ACompleted· 130 enrolled
Drug / intervention
Evolution® Esophageal Stent - Fully Covereddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
In Brief
A clinical study evaluating Evolution® Esophageal Stent - Fully Covered for Esophageal Fistula and 4 related conditions. Completed, enrolled 130 participants across 11 sites.
Detailed Summary
The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Fistula, Esophageal Neoplasms, Esophageal Perforation, Esophageal Stenosis, Stents
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 2013
Enrollment StartSep 2013
Primary CompletionDec 2018
TodayJul 2026
First PostedJul 16, 2013
Enrollment StartSep 1, 2013
Primary CompletionDec 10, 2018
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 13.0 years ago
Interventions
Evolution® Esophageal Stent - Fully Covereddevice
Placement of the Evolution® Esophageal Stent for benign or malignant strictures, fistulas, perforations or leaks with the intention of removal